A Phase 1/2 interventional study of Umbilical Cord Mesenchymal Stem Cells and Conditioned Medium in Cerebral Palsy, sponsored by PT. Prodia Stem Cell Indonesia. Active, not recruiting at 1 site in Indonesia. Open to participants aged 6 Months to 3 Years. Per ClinicalTrials.gov, last updated 2026-02-25.
Sponsored by PT. Prodia Stem Cell Indonesia · Phase 1/2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The aim of this study was to compare the effectiveness of umbilical cord mesenchymal stem cells (UCMSCs) and conditioned medium (CM) administration, UCMSCs only and control with standard therapy.
Hypothesis: UCMSCs + CM therapy resulting in higher improvement in cognitive function, gross motor function and chemical factors than UCMSCs and standard therapy.
1,939 studies on the registry are indexed under Cerebral Palsy; 457 are open to participants now.
This study's planned enrollment of 78 is above the median of 34 across 1,432 interventional studies indexed under Cerebral Palsy.
Browse Cerebral Palsy studies →PT. Prodia Stem Cell Indonesia is the lead sponsor of 16 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
UCMSCs + CM is administered via intrathecal injection
Biological: Umbilical Cord Mesenchymal Stem Cells · Biological: Conditioned Medium
UCMSCs is administered via intrathecal injection
Biological: Umbilical Cord Mesenchymal Stem Cells
Physiotherapy
Other: Standard Therapy
The umbilical cord was removed from the donor and brought to cell culture facility immediately. Upon arrival, pre-sterility sample testing was performed to ensure the sample was free from contaminant. Culture processes were conducted in a laboratory room where high sterility and safety were guaranteed. Every batch of the cells was monitored by a series of quality control testing to assure the quality of the product.
Also known as: Allogeneic Mesenchymal Stem Cells
Conditioned medium collected from umbilical cord mesenchymal stem cell (UC-MSC) cultured. Every batch of the conditioned medium was monitored by a series of quality control testing to assure the quality of the product.
Also known as: Umbilical Cord Mesenchymal Stem Cells derived Conditioned Medium
Standard therapy for cerebral palsy such as physiotherapy
Also known as: Physiotheraphy
Gross Motor Function
Gross Motor Function Classification System (GMFCS)
Time frame: 3 month after stem cells
Gross Motor Function
Gross Motor Function Classification System (GMFCS)
Time frame: 6 month after stem cells
Gross Motor Function
Gross Motor Function Measure (GMFM)
Time frame: 3 month after stem cells
Gross Motor Function
Gross Motor Function Measure (GMFM)
Time frame: 6 month after stem cells
Cognitive Function
Bayley Scales of Infant Development (BSID) version III
Time frame: 3 month after stem cells
Cognitive Function
Bayley Scales of Infant Development (BSID) version III
Time frame: 6 month after stem cells
Chemical Marker
Insulin-like growth factor 1 (IGF-1); stromal derived factor-1α (SDF-1α); brain derived neurotrophic factors (BDNF), Vascular endothelial growth factor (VEGF),glial cell line-derived neutrophic factor (GDNF), fibroblast growth factor (FGF), Doublecortin (DCX)
Time frame: 3 month after stem cells
Chemical Marker
Insulin-like growth factor 1 (IGF-1); stromal derived factor-1α (SDF-1α); brain derived neurotrophic factors (BDNF), Vascular endothelial growth factor (VEGF),glial cell line-derived neutrophic factor (GDNF), fibroblast growth factor (FGF), Doublecortin (DCX)
Time frame: 6 month after stem cells
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2021 (actual). Primary completion is estimated for Jul 2026, 57 months after the start.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Solizmestrocel
PT. Prodia Stem Cell Indonesia